SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice.
Trial Description
Deficits in the management of common symptoms cause substantial morbidity for cancer
patients.Because the health care delivery system is structured to be reactive and not
proactive, there are missed opportunities to optimize symptom control. Growth in Internet
access and proliferation of smartphones has created an opportunity to re-engineer cancer care
delivery. Electronic symptom tracking and feedback is a promising strategy to improve symptom
control. Electronic patient reported outcome (ePRO) monitoring of cancer symptoms has been
shown to decrease symptom burden, improve quality of life, reduce acute care and even extend
survival. SIMPRO will use functioning ePRO prototypes to create and refine the electronic
symptom management system eSyM
Eligibility Requirements
Inclusion Criteria:
Activity 1 Population:
- Age ≥ 18 years
- The potential stakeholders are: patient advisory council members, health system
leaders, clinicians, clinic support staff/administration, IT/Informatics staff
Activity 3 Population:
- Age ≥ 18 years
- Priority population will be patients who meet one of the following:
- Suspected thoracic cancer [lung or bronchus] AND is inpatient following thoracic
surgery.
- Suspected gastrointestinal cancer [colorectal, pancreas, liver/biliary,
esophagus,or gastric] AND is inpatient following gastrointestinal surgery.
- Suspected gynecologic cancer [ovary, uterus, or cervix] AND is inpatient
following gynecologic surgery.
- Diagnosis of thoracic cancer [lung or bronchus] AND scheduled to start a new
treatment plan for thoracic cancer.
- Diagnosis of gastrointestinal cancer [colorectal, pancreas, liver/biliary,
esophagus,or gastric] AND scheduled to start a new treatment plan for
gastrointestinal cancer.
- Diagnosis of gynecologic cancer [ovary, uterus, or cervix] AND scheduled to start
a new treatment plan for gynecologic cancer.
- Total population allowed to use eSyM:
- Any patient at any participating site.
Activity 4 Population:
- Age ≥ 18 years
- Priority population will be patients who meet one of the following:
- Suspected thoracic cancer [lung or bronchus] AND is inpatient following thoracic
surgery.
- Suspected gastrointestinal cancer [colorectal, pancreas, liver/biliary,
esophagus,or gastric] AND is inpatient following gastrointestinal surgery.
- Suspected gynecologic cancer [ovary, uterus, or cervix] AND is inpatient
following gynecologic surgery.
- Diagnosis of thoracic cancer [lung or bronchus] AND scheduled to start a new
treatment plan for thoracic cancer.
- Diagnosis of gastrointestinal cancer [colorectal, pancreas, liver/biliary,
esophagus,or gastric] AND scheduled to start a new treatment plan for
gastrointestinal cancer.
- Diagnosis of gynecologic cancer [ovary, uterus, or cervix] AND scheduled to start
a new treatment plan for gynecologic cancer.
- Total population allowed to use eSyM:
- Any patient at any participating site.